CMBA
CBST

C.M. Bidwell & Associates’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

C.M. Bidwell & Associates’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,270
Closed -$208K – 274
2013
Q3 		$208K Sell
3,270
-20
-0.6% -$1.21K 0.06% 147
2013
Q2 		$159K Buy
+3,290
New +$162K 0.05% 165

Other funds holding CBST

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

C.M. Bidwell & Associates's CBST Position: Q4 2013 in Review

C.M. Bidwell & Associates sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2013, closing a stake of 3,270 shares — an estimated $208K sold.

C.M. Bidwell & Associates first reported a position in CBST in Q2 2013 and held it in 2 quarters. The position peaked at $208K in Q3 2013. 276 funds tracked by Wall St. Rank hold CBST as of Q4 2013.

  • C.M. Bidwell & Associates reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 3,270 CUBIST PHARMACEUTICALS INC shares in Q4 2013, an estimated $208K.
  • C.M. Bidwell & Associates first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • C.M. Bidwell & Associates's CUBIST PHARMACEUTICALS INC position peaked at $208K in Q3 2013.
  • 276 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2013.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2013, filed 12 Feb 2014.